补益肺肾汤加减结合异丙托溴铵治疗慢性阻塞性肺疾病的应用  

Treatment of Chronic Obstructive Pulmonary Disease by Adding and Subtracting Buyi Feishen Tang Combined with Ipratropium Bromide

作　　者：叶雅逵 YE Yakui(Dehua County Chunmei Township Health Center,Quanzhou 362505,China)

机构地区：[1]德化县春美乡卫生院,福建泉州362505

出　　处：《中国医药指南》2023年第35期116-118,共3页Guide of China Medicine

摘　　要：目的研究补益肺肾汤加减结合异丙托溴铵治疗慢性阻塞性肺疾病(COPD)的应用效果。方法选择2022年5月16日至2023年5月16日德化县中医院收治的COPD患者100例作为研究对象,将其按照随机数字表法分为对照组(n=50例,实行异丙托溴铵单独治疗)与试验组(n=50例,实行补益肺肾汤加减联合异丙托溴铵治疗)。对比两组生活质量、症状改善、呼吸功能以及不良反应情况。结果试验组呼吸功能、症状改善以及生活质量均优于对照组(均P<0.05);试验组不良反应发生率低于对照组(P<0.05)。结论补益肺肾汤加减结合异丙托溴铵治疗慢性阻塞性肺疾病具有显著疗效,能够改善患者的呼吸功能,减轻症状,并提高生活质量。Objective Study the application effect of modified Buyi Feishen Tang combined with ipratropium bromide in the treatment of chronic obstructive pulmonary disease(COPD).Methods One hundred COPD patients admitted to Dehua County Hospital of Traditional Chinese Medicine from May 16,2022 to May 16,2023 were selected as study subjects,and they were divided into a control group(n=50 cases,treated with ipratropium bromide alone)and an experimental group(n=50 cases,treated with tonifying lung and kidney soup plus reduction combined with ipratropium bromide)according to the method of randomised numerical table.Quality of life,symptom improvement,respiratory function,and adverse effects were compared between the two groups.Results Respiratory function,symptom improvement,and quality of life were better in the test group than in the control group(all P<0.05);The incidence of adverse reactions was lower in the test group than in the control group(P<0.05).Conclusions The combination of modified Buyi Feishen Tang and ipratropium bromide has significant therapeutic effects on chronic obstructive pulmonary disease,which can improve patients'respiratory function,alleviate symptoms,and improve quality of life.

关 键 词：慢性阻塞性肺疾病 补益肺肾汤加减 异丙托溴铵 

分 类 号：R256.12[医药卫生—中医内科学]